; and (2) shall establish and maintain an advisory group and a stakeholder group for purposes of seeking such assistance. (e) Initial meeting The Board shall hold its initial meeting not later than 90 days after the date of the enactment of this Act. (f) Banned individuals (1) Drug company lobbyists No former registered drug manufacturer lobbyist— (A) may be appointed to the position of Director of the Office; or (B) may be employed by the Office during the 6-year period beginning on the date on which the registered lobbyist terminates its registration in accordance with section 4(d) of the Lobbying Disclosure Act of 1995 ( 2 U.S.C. 1603(d) ) or the agent terminates its status, as applicable. (2) Senior executives of law-breaking companies No former senior executive of a covered entity— (A) may be appointed to the position of Director of the Office; or (B) may be employed by the Office during the 6-year period beginning on the later of— (i) the date of the settlement; and (ii) the date on which the enforcement action has concluded. (3) Covered entity The term covered entity means any entity that is— (A) a drug manufacturer; and (B) (i) operating under Federal settlement, including a Federal consent decree